CRP Amends Option Plan
143851\4837-6121-2588
NEWS RELEASE 19-17 November 7, 2019
CHATHAM ROCK PHOSPHATE AMENDS OPTION PLAN
WELLINGTON New Zealand – Chatham Rock Phosphate Limited (TSXV: “NZP” and
NZAX: “CRP”, “Chatham” or the “Company") wishes to advise that its Board of Directors
has approved an amendment to the Company’s Stock Option Plan which allows stock options
to be granted with a term of up to ten years, as permitted by TSX Venture Exchange policies.
Prior to the amendment of the Stock Option Plan, the Company was restricted to granting
options with a maximum term of five years. The Stock Option Plan amendment is subject to
ratification by shareholders at the 2020 Annual General Meeting. Although the Company
may grant options with terms of up to ten years prior to shareholder ratification, in the event
shareholders do not ratify the amendment, any such options will be deemed to have been
amended to reduce the term to five years from the date of grant.
Chris Castle, President and CEO
chris@crpl.co.nz or +64 21 55 81 85
Skype: phosphateking
Neither the Exchange, its Regulation Service Provider (as that term is defined under the policies of the
Exchange), or NZX Limited has in any way passed upon the merits of the Transaction and associated
transactions, and has neither approved nor disapproved of the contents of this press release.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice – Issue of Options2019-09-11
“Page 1 of 1 11 September 2019 Capital Change Notice This notice is given under NZX Listing Rule 3.13.1 and relates to the unlisted Options to acquire ordinary shares in the Company (‘Options’) issued under the Fisher & Paykel Healthcare 2019 Share Option Plan (the ‘Option Pl…”
- CNU — Chorus Limited: Dividend Reinvestment Plan: Notification of issue of securi2019-10-07
“Chorus Limited Level 10, 1 Willis Street P O Box 632 Wellington New Zealand Email: company.secretary@chorus.co.nz STOCK EXCHANGE ANNOUNCEMENT 8 October 2019 Dividend Reinvestment Plan: Notification of issue of securities Chorus Limited has issued 4,421,…”
- CNU — Chorus Limited: Issue of performance share rights2019-09-09
“Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) The PSRs have been issued under Chorus’ Long Term Incentive Plan. Board resolutions dated 23 August 2019. Total number of Finan…”